Higher susceptibility of NOD/LtSz-scid Il2rg^−/− NSG mice to xenotransplanted lung cancer cell lines

References

• SarteletHDurrieuLFontaineFNyalendoCHaddadEDescription of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) miceIn Vivo2012261192922210712
   PubMed Web of Science ®Google Scholar
• ShultzLDIshikawaFGreinerDLHumanized mice in translational biomedical researchNat Rev Immunol20077211813017259968
   PubMed Web of Science ®Google Scholar
• WenQLMengMBYangBEndostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in miceCancer Sci200910081510151919459845
   PubMed Web of Science ®Google Scholar
• NavabRStrumpfDBandarchiBPrognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancerProc Natl Acad Sci U S A2011108177160716521474781
   PubMed Web of Science ®Google Scholar
• JohnTKohlerDPintilieMThe ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancerClin Cancer Res201117113414121081655
   PubMed Web of Science ®Google Scholar
• DanielVCMarchionniLHiermanJSA primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitroCancer Res20096983364337319351829
   PubMed Web of Science ®Google Scholar
• MerkJRolffJBeckerMLeschberGFichtnerIPatient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?Eur J Cardiothorac Surg200936345445919502076
   PubMed Web of Science ®Google Scholar
• SugamuraKAsaoHKondoMThe interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCIDAnnu Rev Immunol1996141792058717512
   PubMed Web of Science ®Google Scholar
• OhboKSudaTHashiyamaMModulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chainBlood19968739569678562967
   PubMed Web of Science ®Google Scholar
• CaoXShoresEWHu-LiJDefective lymphoid development in mice lacking expression of the common cytokine receptor gamma chainImmunity1995232232387697543
   PubMed Web of Science ®Google Scholar
• DiSantoJPMüllerWGuy-GrandDFischerARajewskyKLymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chainProc Natl Acad Sci U S A19959223773817831294
   PubMed Web of Science ®Google Scholar
• MachidaKSuemizuHKawaiKHigher susceptibility of NOG mice to xenotransplanted tumorsJ Toxicol Sci200934112312719182442
   PubMed Web of Science ®Google Scholar
• SuemizuHMonnaiMOhnishiYItoMTamaokiNNakamuraMIdentification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) miceInt J Oncol200731474175117786304
   PubMed Web of Science ®Google Scholar
• MiyakawaYOhnishiYTomisawaMEstablishment of a new model of human multiple myeloma using NOD/SCID/gammac(null) (NOG) miceBiochem Biophys Res Commun2004313225826214684154
   PubMed Web of Science ®Google Scholar
• QuintanaEShackletonMSabelMSFullenDRJohnsonTMMorrisonSJEfficient tumour formation by single human melanoma cellsNature2008456722259359819052619
   PubMed Web of Science ®Google Scholar
• AglianoAMartin-PaduraIMancusoPHuman acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strainsInt J Cancer200812392222222718688847
   PubMed Web of Science ®Google Scholar
• KanajiNBandohSFujitaJIshiiTIshidaTKuboACompensation of type I and type II cytokeratin pools in lung cancerLung Cancer200755329530217161499
   PubMed Web of Science ®Google Scholar
• FoghJFoghJMOrfeoTOne hundred and twenty-seven cultured human tumor cell lines producing tumors in nude miceJ Natl Cancer Inst1977591221226327080
   PubMed Web of Science ®Google Scholar
• JonesAMHansonIMArmstrongGRO’DriscollBRValue and accuracy of cytology in addition to histology in the diagnosis of lung cancer at flexible bronchoscopyRespir Med20019537437811392578
   PubMed Web of Science ®Google Scholar
• DattaDLahiriBPreoperative evaluation of patients undergoing lung resection surgeryChest20031232096210312796194
   PubMed Web of Science ®Google Scholar
• OieHKRussellEKCarneyDNGazdarAFCell culture methods for the establishment of the NCI series of lung cancer cell linesJ Cell Biochem Suppl19962424318806091
   PubMedGoogle Scholar
• ZhangXClaerhoutSPratAA renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft modelsCancer Res201373154885489723737486
   PubMed Web of Science ®Google Scholar
• GandaraDRLiTLaraPNJrAlgorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneityClin Lung Cancer201213532132522677432
   PubMed Web of Science ®Google Scholar
• MetelitsaLSNaidenkoOVKantAHuman NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cellsJ Immunol200116763114312211544296
   PubMed Web of Science ®Google Scholar
• AgahRMalloyBSherrodABeanPGirgisEMazumderATherapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factorJ Biol Response Mod1988721401513258905
   PubMedGoogle Scholar
• LalaPKElkashabMKerbelRSParharRSCure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: characteristics of killer cells generated in situInt Immunol1990212114911582090199
   PubMed Web of Science ®Google Scholar
• ItohKTildenABBalchCMLysis of human solid tumor cells by lymphokine-activated natural killer cellsJ Immunol198613610391039153084648
   PubMed Web of Science ®Google Scholar
• RobinsonBWMorstynGNatural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cellsCell Immunol198710622152223494538
   PubMed Web of Science ®Google Scholar
• Stein-StreileinJGuffeeJRamosMPitchenikAESpontaneous lymphokine activated killer (LAK) activity in bronchoalveolar lavage cells from patients with bronchogenic carcinomaReg Immunol1989263703752485685
   PubMedGoogle Scholar
• PitchenikAEGuffeeJStein-StreileinJLung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinomaAm Rev Respir Dis19871366132713323500659
   PubMed Web of Science ®Google Scholar
• EsendagliGBruderekKGoldmannTMalignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancerLung Cancer2008591324017825949
   PubMed Web of Science ®Google Scholar
• MatsumoriYYanoSGotoHZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer modelOncol Res2006161152616783964
   PubMed Web of Science ®Google Scholar
• CuiRYoshiokaMTakahashiFIshidaHIwakamiSTakahashiKVinorelbine is effective for the malignant pleural effusion associated with lung cancer in miceAnticancer Res2008283A1633163918630520
   PubMed Web of Science ®Google Scholar